Total Holdings
33
Portfolio diversification across 33 positions
FBT
(NYSEARCA)First Trust NYSE Arca Biotechnology Index Fund
$210.04-- (--)
Loading... - Market loading
FBT ETF Holdings: First Trust NYSE Arca Biotechnology Index Fund
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$2.41B
Total fund assets
Expense Ratio
0.54%
Annual management fee
Fund Issuer
First Trust
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 33 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Moderna, Inc. | Stock | 4.17% |
| 2 |  | Gilead Sciences, Inc. | Stock | 4.04% |
| 3 |  | Illumina, Inc | Stock | 3.89% |
| 4 |  | Alkermes plc | Stock | 3.85% |
| 5 |  | Regeneron Pharmaceuticals, Inc | Stock | 3.80% |
| 6 |  | Incyte Corporation | Stock | 3.78% |
| 7 |  | Amgen Inc. | Stock | 3.76% |
| 8 |  | Natera, Inc | Stock | 3.70% |
| 9 |  | BioNTech SE | Stock | 3.65% |
| 10 |  | ACADIA Pharmaceuticals Inc | Stock | 3.64% |
| 11 |  | argenx SE | Stock | 3.61% |
| 12 |  | Bruker Corporation | Stock | 3.60% |
| 13 |  | Halozyme Therapeutics, Inc. | Stock | 3.60% |
| 14 | B BGNE | BeiGene, Ltd | Stock | 3.58% |
| 15 |  | Corcept Therapeutics Incorporated | Stock | 3.58% |
| 16 |  | Exact Sciences Corporation | Stock | 3.50% |
| 17 |  | Bio-Techne Corporation | Stock | 3.50% |
| 18 |  | Krystal Biotech, Inc | Stock | 3.49% |
| 19 |  | BeOne Medicines AG | Stock | 3.49% |
| 20 |  | Waters Corporation | Stock | 3.48% |
| 21 |  | Veracyte, Inc | Stock | 3.44% |
| 22 |  | Biogen Inc | Stock | 3.42% |
| 23 |  | Neurocrine Biosciences, Inc. | Stock | 3.40% |
| 24 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.39% |
| 25 |  | Exelixis, Inc | Stock | 3.39% |
| 26 |  | United Therapeutics Corporation | Stock | 3.34% |
| 27 |  | Mettler-Toledo International Inc | Stock | 3.32% |
| 28 |  | BioMarin Pharmaceutical Inc. | Stock | 3.27% |
| 29 |  | Repligen Corporation | Stock | 3.12% |
| 30 |  | Genmab A/S | Stock | 3.12% |
| 31 |  | Alnylam Pharmaceuticals, Inc | Stock | 3.05% |
| 32 |  | NeoGenomics, Inc. | Stock | 3.04% |
| 33 |  | Sarepta Therapeutics, Inc | Stock | 2.42% |